Consolidated statement of changes in equity
January 1 – June 30
|
|
|
|
|
Attributable to shareholders of medmix Ltd |
|
|
|
|
||||||||||
|
millions of CHF |
|
|
Share capital |
|
Retained earnings |
|
Treasury shares |
|
Cash flow hedge reserve |
|
Currency translation adjustment |
|
Total |
|
Non-controlling interests |
|
Total equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity as of January 1, 2024 |
|
|
|
0.4 |
|
529.8 |
|
–15.2 |
|
–0.9 |
|
–48.7 |
|
465.4 |
|
9.0 |
|
474.3 |
|
Comprehensive income for the period: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
5.2 |
|
|
|
|
|
|
|
5.2 |
|
0.4 |
|
5.6 |
|
– Cash flow hedges, net of tax |
|
|
|
– |
|
– |
|
– |
|
–2.6 |
|
– |
|
–2.6 |
|
– |
|
–2.6 |
|
– Remeasurements of defined benefit plans, net of tax |
|
|
|
– |
|
0.9 |
|
– |
|
– |
|
– |
|
0.9 |
|
– |
|
0.9 |
|
– Currency translation differences |
|
|
|
– |
|
– |
– |
– |
– |
– |
– |
15.6 |
|
15.6 |
|
0.4 |
|
16.0 |
|
Other comprehensive income |
|
|
|
– |
|
0.9 |
|
– |
|
–2.6 |
|
15.6 |
|
13.9 |
|
0.4 |
|
14.3 |
|
Total comprehensive income for the period |
|
|
|
– |
|
6.1 |
|
– |
|
–2.6 |
|
15.6 |
|
19.1 |
|
0.8 |
|
19.9 |
|
Sale of investments in subsidiaries |
|
|
– |
|
–0.2 |
|
– |
|
– |
|
– |
|
–0.2 |
|
– |
|
–0.2 |
|
|
Subsequent measurement of put option liabilities |
|
|
– |
|
–3.2 |
|
– |
|
– |
|
– |
|
–3.2 |
|
– |
|
–3.2 |
|
|
Contribution to the Sulzer group |
|
|
|
– |
|
–0.1 |
|
– |
|
– |
|
– |
|
–0.1 |
|
– |
|
–0.1 |
|
Transactions with owners of the company: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of treasury shares to share plan participants |
|
|
– |
|
–1.1 |
|
1.1 |
|
– |
|
– |
|
– |
|
– |
|
– |
|
|
Purchase of treasury shares |
|
|
– |
|
– |
|
–0.5 |
|
– |
|
– |
|
–0.5 |
|
– |
|
–0.5 |
|
|
Share-based payments |
|
|
|
– |
|
0.8 |
|
– |
|
– |
|
– |
|
0.8 |
|
– |
|
0.8 |
|
Dividends to shareholders of medmix Ltd |
|
|
– |
|
–20.4 |
|
– |
|
– |
|
– |
|
–20.4 |
|
– |
|
–20.4 |
|
|
Equity as of June 30, 2024 |
|
|
|
0.4 |
|
511.6 |
|
–14.6 |
|
–3.6 |
|
–33.0 |
|
460.8 |
|
9.8 |
|
470.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity as of January 1, 2025 |
|
|
|
0.4 |
|
498.9 |
|
–14.5 |
|
–6.0 |
|
–42.4 |
|
436.4 |
|
10.3 |
|
446.7 |
|
Comprehensive income for the period: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
6.8 |
|
|
|
|
|
|
|
6.8 |
|
0.1 |
|
6.9 |
|
– Cash flow hedges, net of tax |
|
|
|
– |
|
– |
|
– |
|
3.1 |
|
– |
|
3.1 |
|
– |
|
3.1 |
|
– Remeasurements of defined benefit plans, net of tax |
|
|
|
– |
|
7.3 |
|
– |
|
– |
|
– |
|
7.3 |
|
– |
|
7.3 |
|
– Currency translation differences |
|
|
|
– |
|
– |
– |
– |
– |
– |
|
–8.9 |
|
–8.9 |
|
–0.9 |
|
–9.8 |
|
Other comprehensive income |
|
|
|
– |
|
7.3 |
|
– |
|
3.1 |
|
–8.9 |
|
1.5 |
|
–0.9 |
|
0.6 |
|
Total comprehensive income for the period |
|
|
|
– |
|
14.1 |
|
– |
|
3.1 |
|
–8.9 |
|
8.3 |
|
–0.8 |
|
7.6 |
|
Subsequent measurement of put option liabilities |
|
|
– |
|
1.4 |
|
– |
|
– |
|
– |
|
1.4 |
|
– |
|
1.4 |
|
|
Transactions with owners of the company: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of treasury shares to share plan participants |
|
|
– |
|
–3.6 |
|
3.6 |
|
– |
|
– |
|
– |
|
– |
|
– |
|
|
Purchase of treasury shares |
|
|
– |
|
– |
|
–1.0 |
|
– |
|
– |
|
–1.0 |
|
– |
|
–1.0 |
|
|
Share-based payments |
|
|
|
– |
|
1.3 |
|
– |
|
– |
|
– |
|
1.3 |
|
– |
|
1.3 |
|
Dividends to shareholders of medmix Ltd |
|
|
– |
|
–20.4 |
|
– |
|
– |
|
– |
|
–20.4 |
|
– |
|
–20.4 |
|
|
Dividends to non-controlling interests in subsidiaries |
|
|
– |
|
–2.0 |
|
– |
|
– |
|
– |
|
–2.0 |
|
–3.1 |
|
–5.1 |
|
|
Equity as of June 30, 2025 |
|
|
|
0.4 |
|
489.6 |
|
–11.9 |
|
–2.9 |
|
–51.3 |
|
424.0 |
|
6.4 |
|
430.5 |